Background The association of cardiorenal syndrome (CRS) with mortality in children with dilated cardiomyopathy (DCM) is unknown. Methods With a modified Schwartz formula, we estimated glomerular filtration rates (eGFR) for children ≥1 year of age with DCM enrolled in the Pediatric Cardiomyopathy Registry at the time of DCM diagnosis and annually thereafter. CRS was defined as an eGFR of <90 mL/min/1.73 m 2 . Children with and without CRS were compared on survival and serum creatinine concentrations (SCr). The association between eGFR and echocardiographic measures was assessed with linear mixed-effects regression models. Results Of 285 eligible children with DCM diagnosed at ≥1 year of age, 93 were evaluable. CRS was identified in 57 of these 93 children (61.3 %). Mean (standard deviation) eGFR was 62.0 (22.6) mL/min/1.73 m 2 for children with CRS and 108.0 (14.0) for those without (P<0.001); median SCr concentrations were 0.9 and 0.5 mg/dL, respectively (P<0.001). The mortality hazard ratio of children with CRS versus those with no CRS was 2.4 (95 % confidence interval 0.8-7.4). eGFR was positively correlated with measures of left ventricular function and negatively correlated with age. Conclusions CRS in children newly diagnosed with DCM may be associated with higher 5-year mortality. Children with DCM, especially those with impaired left ventricular function, should be monitored for renal disease.
Introduction
Cardiorenal syndrome (CRS) describes a variety of acute and chronic conditions in which the primary failing organ can be Electronic supplementary material The online version of this article (doi:10.1007/s00467-015-3165-8) contains supplementary material, which is available to authorized users.
either the heart or the kidney [1] . Although the term BCRSŵ as not introduced until 2004 by the National Heart, Lung, and Blood Institute Working Group, the association between worsening kidney function and worsening heart function was recognized in the 1980s [2] . The syndrome was first defined as a condition characterized by the initiation or progression of renal insufficiency secondary to heart failure. However, this definition does not describe the negative effects of decreased kidney function on the cardiovascular system [3] .
CRS can be sub-classified into five types [4] . Although several studies have looked at acute CRS (type I) in infants undergoing cardiopulmonary bypass [5, 6] , studies of children with chronic left ventricular (LV) dysfunction, such as dilated cardiomyopathy (DCM), are lacking.
In adults, chronic cardiac abnormalities resulting in impaired kidney function are associated with adverse outcomes and prolonged hospitalizations [3, 7] , and the prevalence of CRS has been reported to be as high as 30 % [8] . The prevalence of CRS in children with chronic systolic dysfunction is unknown. Price et al. reported that 48 % (35/73) of children with acute decompensated heart failure had an increased serum creatinine (SCr) concentration of ≥0.3 mg/dL from baseline and that elevated concentrations were associated with increased mortality or the need for mechanical ventricular assistance [9] . However, these authors did not report the prevalence of kidney dysfunction at the time of the primary heart disease diagnosis or describe kidney function in patients with compensated heart failure. Another recent study showed that elevated levels of an additional renal biomarker, fibroblast growth factor 23 (FGF23), were associated with heart failure severity in children [10] . To our knowledge, epidemiological data on CRS in children with DCM have not been published.
The North American Pediatric Cardiomyopathy Registry (PCMR) reported the incidence of cardiomyopathy to be 0.57 per 100,000 children. Dilated cardiomyopathy accounts for more than 50 % of these cases [11, 12] . Among congenital and acquired heart diseases in children, DCM has one of the highest mortality rates [13] . Even with advanced medical care, the 5-year mortality rate for children with DCM has remained at 17 % over the past two decades [13] , and freedom from death or transplantation 5 years after diagnosis is reported to be 54 % [12] . Whether kidney dysfunction contributes to mortality in these children is unknown. Unfortunately, chronic kidney disease (CKD) is often underdiagnosed in children [14] . Children with CRS represent a unique high-risk subgroup of children with CKD because of the additive morbidity and mortality of CKD in addition to the risk of heart disease. In the absence of known predictive risk factors for CRS in children, recognizing kidney dysfunction in children with DCM seems to be challenging, especially because this group of children is followed mainly by pediatric cardiologists.
We sought to determine (1) the prevalence and outcomes of CRS in children with newly diagnosed DCM, (2) the accuracy of interpreting SCr concentration as a marker of CRS, and (3) the association between CRS and LV function.
Materials and methods

Methods
The PCMR is a National Heart, Lung, and Blood Institutefunded registry established to describe the epidemiologic features and clinical course of cardiomyopathies in children up to 18 years of age and to promote the development of causespecific treatments [15] . The registry has entered data from more than 3500 children diagnosed since 1990 with different types of cardiomyopathies enrolled by almost 100 pediatric cardiomyopathy centers in USA and Canada.
Data in the PCMR were derived from two different cohorts. The first was a retrospective cohort identified from a review of medical records for diagnoses made between 1 January 1990 and 31 December 1995. The second was a prospective cohort of cases diagnosed after 31 December 1995. Children with specific secondary causes of myocardial abnormalities, such as congenital heart disease, endocrine disorders known to cause myocardial damage, history of chemotherapy or pharmacology-associated cardiotoxicity, chronic arrhythmia, and pulmonary parenchymal or vascular disease, were excluded. Once a patient was enrolled in the PCMR, an enrollment form containing demographic, clinical, and diagnostic data from the first 30 days after diagnosis was submitted (defined as baseline data). Follow-up forms completed by annual chart review were also submitted. Data on LV ejection fraction were captured only later in the study and are therefore available for fewer than half of the subjects. Each participating center obtained Institutional Review Board or Ethics Committee approval for the study.
Cardiomyopathy is a general term describing various phenotypes of heart muscle disease with different physiologies and prognoses. To avoid the confounding effect of these different phenotypes, we included only children with a diagnosis of DCM. The analysis used the PCMR database as of November 2011.
Design and measurements
Patients with a diagnosis of DCM who had at least one SCr concentration reported in the registry for the calculation of the eGFR were analyzed. Subjects younger than 1 year of age at registry entry and those with an eGFR of>150 ml/min/1.73 m 2 were excluded.
We used only the baseline data to determine the prevalence of CRS in children at the time of DCM diagnosis and classified these baseline SCr concentrations as normal or abnormal.
Patients with DCM in the PCMR met at least one of the following criteria: (1) strict echocardiographic criteria for DCM {LV dilation [i.e., LV end-diastolic dimension (LVEDD) >2 standard deviations (SD) above normal for body surface area] and depressed LV systolic function [LV fractional shortening (LVFS) or LV ejection fraction (LVEF) >2 SD below normal for age]}; (2) pathologic findings consistent with DCM at autopsy or by endomyocardial biopsy; (3) other clinical evidence of DCM provided by the cardiologist [15] .
We defined CRS as an estimated glomerular filtration rate (eGFR) of <90 mL/min/1.73 m 2 , as per the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative stratification of decreased eGFR [16] . The eGFR was calculated using the modified Schwartz formula [17, 18] :
Children aged <1 year were excluded because Schwartz and colleagues reported this formula in CKD only for children more than 1 year old.
Whether glomerular hyperfiltration, regardless of proteinuria, is a sign of kidney injury is unknown, and neither the definition nor the implications of hyperfiltration are clear in clinical practice. Furthermore, hyperfiltration has been defined with different thresholds, with an eGFR range of 120 to 150 mL/min/1.73 m 2 [19] [20] [21] . Unfortunately, the PCMR does not collect urinalysis data. Thus, we excluded children with an eGFR of >150 mL/min/1.73 m 2 from our analysis. We compared demographic and clinical characteristics and survival rates between children with and without CRS. The accuracy of describing SCr concentrations as Bnormal^or Babnormal^as documented in the medical record was analyzed to evaluate the recognition of decreased eGFR among healthcare providers.
We used both the baseline and the annual follow-up data to determine the prevalence of CRS annually for 5 years after DCM diagnosis, to evaluate the effect of CRS on 5-year mortality rates, and to assess the association between eGFR and the values and Z-scores for six echocardiographic measures: LVFS, LVEF, LVEDD, LV end-systolic dimension (LVESD), LVend-diastolic posterior wall thickness (PWT), end-diastolic septal thickness (IVS), as well as the calculated PWT:LVEDD ratio (a measure of LV remodeling, with small values reflecting disproportionate left ventricular dilation relative to wall thickness). Z-scores were calculated to body surface area.
Statistical methods
Categorical data are presented as counts and percentages and were analyzed with the chi-square and Fisher's exact tests. Skewed distributions are described with medians and interquartile ranges (IQR) and were compared with a Wilcoxon rank sum test. Normal distributions are described with means and SD and compared with Student's t test. Agreement between the classification of SCr by primary providers as normal or abnormal and the gold standard of eGFR as normal, i.e., eGFR ≥90 mL/min/1.73 m 2 , or abnormal, i.e., eGFR <90 mL/ min/1.73 m 2 , was assessed with the kappa statistic (κ). To estimate survival, time to heart transplantation, and the composite of the earliest occurring of death or transplantation as a function of CRS status, we utilized an adjusted-risk set method that accommodates left-truncated data [22] . This strategy allows the cases without available eGFR data at the time of diagnosis (baseline) but with a later available eGFR value to enter the Kaplan-Meier plots and Cox regression models at the time when the first eGFR value becomes available for each case. This approach was adopted to increase the power of the analyses given the relatively small number of available eGFR values (ability to assign CRS classification) at the time of diagnosis. Simple linear mixed-effects regression models were applied to study the association between the response variable eGFR and the raw values and Z-scores of echocardiographic measures of LV size and function. Multivariable mixed-effects models were applied in order to adjust for age while evaluating the correlation between serial eGFR and echocardiographic measures. Outliers were detected using jackknife residuals, and normality was tested with the Kolmogorov-Smirnov test. Two LVFS observations were recognized as outliers and were excluded. Alpha was set at 0.05. The analyses were conducted using SAS versions 9.2 and 9.3 (SAS Institute Inc., Cary, NC) and Microsoft EXCEL 2010 (Microsoft Corp., Redmond, WA). Kaplan-Meier plots were created using the statistical software package R ® (Foundation for Statistical Computing, Vienna, Austria).
Results
Between January 1990 and November 2011, 3559 children were registered in the PCMR. Of these, 2141 (60 %) had a diagnosis of DCM, but only 484 (23 %) had at least one SCr concentration reported in baseline or annual data. eGFR could be calculated for 105 children in the baseline data after excluding children aged <1 year, and 219 eGFRs were calculated from the annual data ( Fig. 1) .
At baseline, the 105 children with assessable eGFR values did not differ from the 180 children without assessable eGFR values with respect to age, race, weight, and height (Electronic Supplementary Material Table 1 ). The two groups did not differ with respect to history of congestive heart failure (CHF), the need for hospitalization, the need for heart transplant evaluation, or any echocardiographic measure.
The distribution of eGFR in the 105 children with accessible eGFR (before exclusion of values >150 mL/min/1.73 m 2 ) in the baseline data stratified into six eGFR ranges is depicted in Fig. 2 .Of these 105 children with baseline eGFR data, 12 (11.5 %) had eGFRs of >150 mL/min/1.73 m 2 and were excluded, leaving 93 children who met all inclusion and exclusion criteria. Of these 93 children, 57 (61.3 %) had an eGFR of <90 mL/min/1.73 m 2 (the CRS group). Creatinine and blood urea nitrogen serum concentrations were significantly higher in children with CRS than in those without CRS. The groups did not differ with respect to age, sex, race, weight, height, history of CHF, echocardiographic measures, the need for hospitalization, or days of hospitalization (Table 1) .
Although the groups differed significantly in mean eGFR and SCr concentrations at the time of DCM diagnosis, they did not differ when SCr concentrations were classified as normal or abnormal by the participating centers' laboratory criteria (43 and 32 % of values classified as abnormal for CRS and non-CRS, respectively). We used eGFR to define ) to validate the accuracy of the primary care providers in recognizing SCr as normal or abnormal (Fig. 3) . There was little to no agreement between the SCr classification by providers and the classification based on eGFR [κ=0.09; 95 % confidence interval (CI) −0.009 to 0.28] (Fig. 3) .
We also enriched the dataset by classifying 122 additional patients as CRS or non-CRS based on their follow-up data and utilizing an adjusted-risk set approach (see Methods). Thus, the enriched dataset included 215 patients. Median follow-up was 3.8 (IQR 0.6-5.0) years for children without CRS and 4.9 (IQR 1.6-6.9) years for children with CRS. Of the 215 patients, 18 died (14 of 105 in the CRS group and 4 of 110 in the non-CRS group; P=0.14), and 57 underwent heart transplant Table 2 ). The hazard ratio for patients with CRS was 2.4 (95 % CI 0.8-7.4) for death, 0.9 (95 % CI 0.5-1.6) for transplant, and 1.1 (95 % CI 0.7-1.8) for the composite of death and transplant (Table 2 ; Fig. 4 ). Using all available data, children with DCM had significantly improved eGFRs, less dilation, and a trend toward improved LV function over time since DCM diagnosis ( Table 3) . The z-scores for both posterior wall thickness and enddiastolic septal thickness became more negative over time, but the thickness-to-dimension ratio did not change, consistent with change in LV mass commensurate with the change in LV volume rather than adverse ventricular remodeling.
A lower eGFR was associated with lower fractional shortening and a higher LVEDD Z-score, LVESD Z-score, and LV mass Z-score (Table 4 , model 1). For example, mean eGFR increased by 0.6 mL/min/1.73 m 2 for every 1 SD increase in LVFS Z-score. The same associations remained significant after adjusting for age. However, eGFR was not associated with echocardiographic measures of wall thickness (LV posterior wall thickness and end-diastolic septal thickness). The negative association between eGFR and age was persistent and significant, regardless of the echocardiographic measure used in the model (Table 4 , model 2). Accordingly, eGFR increases as LVFS improves and as LV dilation diminishes, and decreases as age increases.
Discussion
The coexistence of compromised kidney function and heart failure in adults is associated with poor prognosis and prolonged hospitalization [3, 8] . Chen et al., using a multifactorial regression model, found that a blood urea nitrogen concentration of >43 mg/dL was the best predictor of mortality in adults admitted for acute decompensating heart failure [23] , a finding which reflected the marked impact of deteriorating kidney function in this population.
DCM is the most common form of cardiomyopathy and the main cause of cardiac transplant in children. Although much CRS-related research has been conducted in adults, similar research in children is limited [24] , and most studies in this area have focused on the implications of CRS in children after cardiopulmonary bypass [5, 25] . We found no studies reporting the prevalence, outcome, and predictors of CRS in children with DCM.
Using the modified Schwartz formula to calculate eGFR and defining CRS as an eGFR of <90 mL/min/1.73 m 2 , we found that the prevalence of CRS in children newly diagnosed with DCM was 61.3 % (57/93). However, Schwartz derived this formula to calculate eGFR in children with known CKD, and it has not been validated in children with DCM. Because the PCMR does not have eGFR data for healthy children, we used data published by Fadrowski et al., who reported the 25th and 50th percentiles for eGFRs in 3256 healthy children to be 84. 4 [3, 9, 11, 26] . The prevalence of CRS in our cohort decreased over time; it was higher during the first (44.2 %) and second (45.0 %) years after diagnosis (Table 3) than it was among Fadrowski et al.'s healthy cohort (36.3 %). After the second year, the prevalence of CRS in our cohort was lower than that in Fadrowski et al.'s cohort; however, our sample was much smaller after the first 2 years (Table 3) .
Unfortunately, the PCMR data suggest that in children with DCM, reporting physicians inconsistently evaluated kidney function and more often than not misinterpreted the markers of kidney dysfunction, such as SCr concentrations. Concentrations of SCr were reported for only 484/2141 (22.6 %) children with DCM over 11 years of data collection. The agreement between our classification of SCr concentrations by eGFR as normal or abnormal and the classification by reporting physicians was poor (κ=0.09). This lack of agreement represents a major deficiency in assessing children with DCM for CRS. However, the poor recognition of kidney dysfunction is not surprising and is consistent with the general underdiagnosis and undertreatment of CKD in the USA [27] .
The identification of children with abnormal kidney function could be facilitated by using the modified Schwartz formula, in addition to the associated normal reference ranges of SCr concentrations. Furthermore, recognizing abnormal kidney function could potentially result in treatment options that would preserve residual kidney function, such as limiting iatrogenic damage from nephrotoxic agents and encouraging the more judicious use of diuretics. Increasing evidence indicates that renal insufficiency in adults with heart failure is an important independent risk factor for death [3, 28, 29] . In our study, the CRS group had qualitatively higher mortality rates (31 vs. 14 % at 5 years). However, these differences were not statistically significant, most likely because of the small number of deaths (only 18 deaths in annual data) in children with and without CRS. Accordingly, we cannot conclude that CRS is associated with increased mortality in children. The rate of successful heart transplants was also similar between the two groups. Fig. 3 Accuracy analysis of reporting serum creatinine. Modified Latin Square of 2 × 2 table for reporting serum creatinine (SCr) values as normal or abnormal compared to the actual status based on estimated glomerular filtration rate (eGFR) using the modified Schwartz formula Table 2 Adjusted-risk set mortality and heart transplantation rates in children with dilated cardiomyopathy aged >1 year by cardiorenal syndrome (CRS) as defined by the initial estimated glomerular filtration rate (eGFR) CI, Confidence interval LV diameter improved significantly and the LV thicknessto-dimension ratio remained stable in survivors in the years after DCM diagnosis. There was a trend toward improvement in LV function with time, but this did not reach statistical significance. Concurrently, eGFR also improved with time after diagnosis. Thus, eGFR may be associated directly with the degree of systolic dysfunction, although other variables may modify this association. An alternative explanation is that survivor bias led to the appearance of better LV function and less LV dilation at later follow-up visits relative to the baseline data that included all subjects.
We also found significant associations between eGFR and several echocardiographic measures, including a positive correlation with LVFS. This significant correlation supports the clinical conclusion that eGFR increases or decreases as LV function improves or worsens, respectively. The literature is not consistent on the association between eGFR and different echocardiographic measures, with some studies reporting a Kaplan-Meier estimates of time to cardiac transplantation in 215 children with DCM by CRS status at baseline (logrank P=0.69). c Kaplan-Meier estimates of time to death or cardiac transplantation in 215 children with DCM by CRS status at baseline (logrank P=0.68). eGFR, estimated glomerular filtration rate correlation [30, 31] and others not [32] . Likewise, studies of novel tubular injury markers, such as kidney injury molecule-1 and N-acetyl-β-(D)-glucosaminidase, have also obtained conflicting results [33] . In healthy children, eGFR increases during infancy and remains steady during childhood and adolescence [34] . In order to eliminate the possibility that the correlation between eGFR and LV function is confounded by age, we created a multivariate model (Table 4 , model 2) with age included as a covariate. The model showed that eGFR and LV function were still correlated after adjusting for age, thereby supporting the presumptive association between heart and kidney functions.
Many mechanisms have been proposed to contribute to the pathogenesis of kidney dysfunction in patients with impaired systolic function. These include salt and water retention, venous congestion with associated elevation of central venous pressure, anemia, and other systemic co-morbidities [35] . However, patients with known endocrine conditions or primary essential hypertension were excluded from this cohort. Further, CRS cannot be interpreted simply as being secondary to decreased renal perfusion that, in turn, is secondary solely to decreased systolic function, as in our cohort. Studies in adults have shown that elevated central venous pressure is important in developing CRS, with elevated pressure in the efferent arterioles of the glomeruli. In the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness study, right atrial pressure, an indicator of venous congestion, correlated with SCr; cardiac index did not [36] . Animal models have shown that eGFR is not always significantly affected after massive myocardial infarction with impaired systolic function [37] , suggesting that other humoral and/or neurological regulators may be involved in the development of CRS. Another potential pathogenic pathway is the maladaptive stimulation of the renin-angiotensin-aldosterone system that leads to additional fluid retention, systemic vascular resistance, and oxidative stress. A chronic inflammatory state has also been described that potentiates further injury to the kidney, including glomerulosclerosis and tubulointerstitial fibrosis [38] . Angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockade, and aldosterone antagonists have been used as treatments for heart failure in both adults and children. To date, no study has been performed in the pediatric patient population with heart failure to assess the use of ACE inhibitors and angiotensin receptor blockers in the presence of CRS; similarly, such studies are also lacking in the adult patient population. If these agents are used in the presence of both DCM-related heart failure and CRS in children, proper adjustment of ACE inhibitor dose is recommended based on the rise in SCr concentration, eGFR, and the presence of hypotension [39] . The impact of these medications on the progression of CRS in pediatric DCM needs further assessment due to the potential for clinical benefit but also the potential for harm due to side effects.
Limitations of the study
Our study is limited by the fact that we used data from a registry designed primarily to characterize children with different forms of cardiomyopathy. As a result, data on kidney function markers were expected to be easily missed and not reported, which reduced the number of records available for analysis and precluded the evaluation of the longitudinal progression or recovery of kidney function in the DCM cohort. Also, different centers may use different assays to measure SCr concentrations, which might increase the variability in these concentrations without any real clinical or pathological reason for this variability. In addition, our cohort includes only children with DCM who had at least one SCr concentration measurement, which may bias the study if children at high risk for kidney insufficiency tend to have SCr concentrations measured more often. Finally, as mentioned previously, observed improvements in echocardiographic parameters over time may be due, at least in part, to survivor bias. 
Conclusions
Our results highlight the likely prevalence of CRS in children with DCM and the association between heart and kidney function using SCr, a simple and commonly used marker of kidney function. Using more sensitive and early markers of renal injury, such as serum cystatin-C, urinary microalbumin, and perhaps the novel renal tubular injury markers, could expand our knowledge of CRS in children with different pathological forms of cardiomyopathy. It has been suggested that children with renal disease should be cared for by a multidisciplinary team which includes pediatric cardiologists, among others [40] . Perhaps the care team for children with DCM should include pediatric nephrologists, which could lead to earlier testing and diagnosis of CRS in this population. Cardiorenal syndrome is likely to be common in children with a recent diagnosis of DCM. Currently, it appears that CRS is underreported and misdiagnosed by cardiologists caring for these children. Despite the fact that mortality is higher in children with CRS than without, the difference was not statistically significant in our study, so conclusions cannot be definitive. Because CRS concentrations are correlated with LV function, we suggest that baseline assessment and surveillance of kidney function should be conducted as part of routine care of children with DCM.
